Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
AstraZeneca
Covington
Colorcon
Merck
McKesson
Moodys
Teva
US Department of Justice

Generated: May 26, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,212,176

« Back to Dashboard

Summary for Patent: 5,212,176
Title: R(+)-terazosin
Abstract:R(+)-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-6,7-dimethoxy-4-q uinazolinamine hydrochloride or a pharmaceutically acceptable salt or hydratet hereof (terazosin), substantially free of the S(-)-enantiomer.
Inventor(s): Kyncl; John J. (Lake Forest, IL), Horrom; Bruce W. (Waukegan, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:07/546,349
Patent Claims: 1. The compound having the name R(+)-2-(4-((tetrahydro-2-furanyl)carbonyl)piperazinyl)-6,7-dimethoxy-4-qui nazolinamine hydrochloride dihydrate having an optical rotation [.alpha.].sub.D.sup.28.5.degree. C. (C=1, water) of 23.9.degree. or greater.

2. A pharmaceutical composition comprising a therapeutically effective amount of the compound as defined by claim 1 in combination with a pharmaceutically acceptable carrier.

3. A method of treating hypertension in a mammal in need of such treatment comprising administering a therapeutically effective amount of of the compound as defined by claim 1.

4. A method of treating benign prostatic hyperplasia in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

5. A method of treating hyperinsulinemia in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

6. A method of treating congestive heart failure in a mammal in need of such treatment comprising administering a therapeutically effective amount of the compound as defined by claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Covington
Fish and Richardson
Cipla
Deloitte
Farmers Insurance
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.